The Ministry of Chemicals and Fertilizers, (MoCF) on August 17, 2023, notified Scheme for Promotion of Research and Innovation in Pharma MedTech Sector (PRIP).
The objective of the scheme is to transform the Indian Pharma MedTech sector from cost-based to innovation-based growth by strengthening the research infrastructure in the country. The aim of the scheme is to promote industry-academia linkage for R&D in priority areas to inculcate a culture of quality research and nurture our pool of scientists. This will lead to sustained global competitive advantage and contribute to quality employment generation in the country.
Salient features of the Scheme:
•Strengthening the research Infrastructure – Setting up of Centres of Excellence at the National Institute of Pharmaceutical Education & Research (NIPERs).
•Encourage the industry to invest in research and development in specific priority areas. Accordingly, it is proposed that financial assistance under the component would be provided to promote R&D in six priority areas.
Impact of the Scheme:
•Focus on certain priority areas which will help India’s pharma industry leapfrog and radically strengthen its position in the world market as innovation accounts for 2/3rd of global pharmaceutical opportunities.
•Development of Research Infrastructure- The scheme would help in building a world-class research atmosphere at NIPERs by establishing CoE and making a talent pool of qualified trained students.
•The scheme would help in launching commercially viable products thereby accelerating the growth of the Indian Pharmaceuticals sector.
[Notification No. No. 50018/2/2022-NIPER]
